Abstract Changes in serum inflammatory factors occur throughout the onset and multiple
myeloma (MM) progression, the feedback loops make it harder to distinguish between …

Background: Multiple myeloma (MM) accounts for 10% of hematologic cancers in the US;
however, incidence and mortality occur disproportionately between racial groups in real …

Multiple myeloma (MM) incidence, mortality, and survival vary by race and ethnicity, but the
causes of differences remain unclear. We investigated demographic, clinical, and molecular …

Background Multiple myeloma (MM) is a severely debilitating and fatal B-cell neoplastic
disease. The discovery of disease-associated proteins with causal genetic evidence offers a …

Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of
malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which …

Several landmark therapeutic advances in multiple myeloma (MM) have led to an
unprecedented number of options available to patients and their physicians as shared …

We performed a systematic review of the literature investigating the demographic and
insurance-related factors linked to disparities in multiple myeloma (MM) care patterns in the …

Background To investigate the prognosis of patients with Multiple Myeloma (MM) after
surgery, analyze the risk factors leading to adverse postoperative outcomes, and establish a …

PURPOSE Little is known about the role of social determinants of health (SDOH) in the
utilization of novel treatments among patients with newly diagnosed multiple myeloma …

Health disparities in multiple myeloma (MM) disproportionately affect minorities.
Characterization of health disparities encountered by Hispanic Americans with MM is …